Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT …

N Worel, P Ljungman, ICM Verheggen… - Bone Marrow …, 2023 - nature.com
The COVID-19 pandemic has had a significant impact on medical practices, including the
delivery of allogeneic hematopoietic cell transplantation (HCT). In response, transplant …

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors

M Leclerc, S Fourati, D Menouche… - The Lancet …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19,
but up to half of people infected with the virus are asymptomatic. 1 Moreover, SARS-CoV-2 …

[HTML][HTML] Pros and Cons of Cryopreserving Allogeneic Stem Cell Products

CG Valentini, C Pellegrino, L Teofili - Cells, 2024 - mdpi.com
The COVID-19 pandemic has precipitously changed the practice of transplanting fresh
allografts. The safety measures adopted during the pandemic prompted the near-universal …

Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic

SM Devine, S Bo-Subait, M Kuxhausen… - Blood …, 2023 - ashpublications.org
At the onset of the COVID-19 pandemic, the National Marrow Donor Program mandated the
cryopreservation of hematopoietic cell grafts from volunteer unrelated donors because of …

[HTML][HTML] 5 years DKMS Chile: approach, results and impact of the first unrelated stem cell donor center in Chile

F Barriga, UV Solloch, A Giani, J Palma… - Frontiers in …, 2023 - frontiersin.org
Introduction Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is performed
worldwide to treat blood cancer and other life-threatening blood disorders. As successful …

Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS registry

AH Schmidt, J Sauter, J Schetelig, E Neujahr… - Best Practice & …, 2024 - Elsevier
Allogeneic hematopoietic stem cell (HSC) transplantation is a curative therapy for many
severe blood diseases. As many patients have no suitable family donor, large unrelated …

The new world: hematopoietic stem cell transplant during a pandemic

M Riches - Current Opinion in Hematology, 2021 - journals.lww.com
The new world: hematopoietic stem cell transplant during a p... : Current Opinion in
Hematology The new world: hematopoietic stem cell transplant during a pandemic : Current …

[HTML][HTML] Registries: A Bridge Between Donor and Recipient

I Evseeva, L Foeken, J Villa - The EBMT Handbook: Hematopoietic Cell …, 2024 - Springer
Registries strive for a world where access to life-saving cellular therapies for all patients is
assured and donors' rights and safety are protected. Through the World Marrow Donor …

Assessing deviations for HPCs obtained during COVID‐19 (ADHOC): Evaluating impact of the COVID‐19 pandemic on cellular therapy products and processes, the …

SR Thibodeaux, D Coble, V Day, MJ Fontaine… - …, 2023 - Wiley Online Library
Background The success of allogeneic hematopoietic stem cell transplantation is dependent
on a world‐wide network of collection centers providing donations that predominantly have …

[HTML][HTML] Serious Stem Cell Donation Events and Recipient Adverse Reactions Related to Severe Acute Respiratory Syndrome Coronavirus 2: Review of Reports to the …

R Pawson, C Anthias, M Cody, M Fechter… - … and Cellular Therapy, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has deeply
impacted hematopoietic stem cell (HSC) donation and transplantation. Numerous changes …